TP53 and androgen insensitivity syndrome: Furthermore, we found that the mutation frequency of TP53 (26% vs. 4%, P<0.0001), MUC16 (15% vs. 4%, P=0.016), and KRAS (14% vs. 3%, P=0.043) was higher in LUAD than in MIA/AIS.